NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Anthera Pharmaceuticals, Inc. ANTH, NRG Energy, Inc. NRG, Antares Pharma, Inc. ATRS, El Pollo Loco Holdings, Inc. LOCO, Paychex, Inc. PAYX, and Cinedigm Corp CIDM, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ANTH DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANTH
NRG DOWNLOAD: http://Fundamental-Markets.com/register/?so=NRG
ATRS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ATRS
LOCO DOWNLOAD: http://Fundamental-Markets.com/register/?so=LOCO
PAYX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PAYX
CIDM DOWNLOAD: http://Fundamental-Markets.com/register/?so=CIDM
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Anthera Pharmaceuticals, Inc. ANTH, NRG Energy, Inc. NRG, Antares Pharma, Inc. ATRS, El Pollo Loco Holdings, Inc. LOCO, Paychex, Inc. PAYX, and Cinedigm Corp CIDM on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 29th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ANTHERA PHARMACEUTICALS, INC. (ANTH) REPORT OVERVIEW
Anthera Pharmaceuticals' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Anthera Pharmaceuticals reported revenue of $0.00MM vs $0.00MM and basic earnings per share -$0.42 vs -$2.03. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Anthera Pharmaceuticals reported revenue of $0.00MM vs $0.15MM and basic earnings per share -$2.86 vs -$12.87. Anthera Pharmaceuticals is expected to report earnings on September 5th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.86.
To read the full Anthera Pharmaceuticals, Inc. (ANTH) report, download it here: http://Fundamental-Markets.com/register/?so=ANTH
-----------------------------------------
NRG ENERGY, INC. (NRG) REPORT OVERVIEW
NRG Energy's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, NRG Energy reported revenue of $2,922.00MM vs $2,701.00MM (up 8.18%) and basic earnings per share $0.23 vs -$1.98. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NRG Energy reported revenue of $10,629.00MM vs $10,512.00MM (up 1.11%) and basic earnings per share -$6.79 vs -$2.22. NRG Energy is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.61. The estimated EPS forecast for the next fiscal year is $4.05 and is expected to report on March 7th, 2019.
To read the full NRG Energy, Inc. (NRG) report, download it here: http://Fundamental-Markets.com/register/?so=NRG
-----------------------------------------
ANTARES PHARMA, INC. (ATRS) REPORT OVERVIEW
Antares Pharma's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Antares Pharma reported revenue of $14.16MM vs $13.42MM (up 5.56%) and basic earnings per share -$0.03 vs -$0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Antares Pharma reported revenue of $54.52MM vs $52.22MM (up 4.39%) and basic earnings per share -$0.11 vs -$0.16. Antares Pharma is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.03. The estimated EPS forecast for the next fiscal year is $0.07 and is expected to report on March 12th, 2019.
To read the full Antares Pharma, Inc. (ATRS) report, download it here: http://Fundamental-Markets.com/register/?so=ATRS
-----------------------------------------
EL POLLO LOCO HOLDINGS, INC. (LOCO) REPORT OVERVIEW
El Pollo Loco's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, El Pollo Loco reported revenue of $111.63MM vs $105.57MM (up 5.74%) and basic earnings per share $0.13 vs $0.20 (down 35.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, El Pollo Loco reported revenue of $401.70MM vs $380.12MM (up 5.68%) and basic earnings per share $0.22 vs $0.48 (down 54.17%). El Pollo Loco is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.73 and is expected to report on March 14th, 2019.
To read the full El Pollo Loco Holdings, Inc. (LOCO) report, download it here: http://Fundamental-Markets.com/register/?so=LOCO
-----------------------------------------
PAYCHEX, INC. (PAYX) REPORT OVERVIEW
Paychex's Recent Financial Performance
For the three months ended May 31st, 2018 vs May 31st, 2017, Paychex reported revenue of $871.10MM vs $798.60MM (up 9.08%) and basic earnings per share $0.65 vs $0.55 (up 18.18%). For the twelve months ended May 31st, 2018 vs May 31st, 2017, Paychex reported revenue of $3,380.90MM vs $3,151.30MM (up 7.29%) and basic earnings per share $2.60 vs $2.27 (up 14.54%). Paychex is expected to report earnings on October 2nd, 2018. The report will be for the fiscal period ending August 31st, 2018. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $3.07 and is expected to report on June 26th, 2019.
To read the full Paychex, Inc. (PAYX) report, download it here: http://Fundamental-Markets.com/register/?so=PAYX
-----------------------------------------
CINEDIGM CORP (CIDM) REPORT OVERVIEW
Cinedigm's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Cinedigm reported revenue of $13.08MM vs $15.24MM (down 14.19%) and basic earnings per share -$0.09 vs -$0.48. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Cinedigm reported revenue of $67.68MM vs $90.39MM (down 25.12%) and basic earnings per share -$0.81 vs -$1.92. Cinedigm is expected to report earnings on November 15th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.60. The estimated EPS forecast for the next fiscal year is -$0.66 and is expected to report on June 24th, 2019.
To read the full Cinedigm Corp (CIDM) report, download it here: http://Fundamental-Markets.com/register/?so=CIDM
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
